BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22090266)

  • 21. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.
    Jacobson DL; Spiegelman D; Knox TK; Wilson IB
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):298-308. PubMed ID: 18845956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal women.
    Villalon KL; Gozansky WS; Van Pelt RE; Wolfe P; Jankowski CM; Schwartz RS; Kohrt WM
    Obesity (Silver Spring); 2011 Dec; 19(12):2345-50. PubMed ID: 21852813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.
    Schneider DL; Barrett-Connor EL; Morton DJ
    JAMA; 1994 Apr; 271(16):1245-9. PubMed ID: 7848399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
    Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis.
    Shaarawy M; Abassi AF; Hassan H; Salem ME
    Fertil Steril; 2003 Apr; 79(4):919-24. PubMed ID: 12749431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
    Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
    Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.
    Ghebre MA; Hart DJ; Hakim AJ; Kato BS; Thompson V; Arden NK; Spector TD; Zhai G
    Calcif Tissue Int; 2011 Oct; 89(4):295-302. PubMed ID: 21789637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Immunodeficiency Virus (HIV) and Menopause Are Independently Associated With Lower Bone Mineral Density: Results From the Women's Interagency HIV Study.
    Sharma A; Hoover DR; Shi Q; Tien PC; Weber KM; Shah JG; Yin MT
    Clin Infect Dis; 2022 Aug; 75(1):65-72. PubMed ID: 34595517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women.
    Calmy A; Chevalley T; Delhumeau C; Toutous-Trellu L; Spycher-Elbes R; Ratib O; Zawadynski S; Rizzoli R
    Osteoporos Int; 2013 Jun; 24(6):1843-52. PubMed ID: 23138338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal period.
    Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A
    Eur J Endocrinol; 2012 May; 166(5):855-60. PubMed ID: 22312036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
    AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study.
    Macdonald HM; Maan EJ; Berger C; Dunn RA; Côté HCF; Murray MCM; Pick N; Prior JC
    Bone; 2020 Sep; 138():115509. PubMed ID: 32599222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of obesity and diabetes on rate of bone density loss.
    Leslie WD; Morin SN; Majumdar SR; Lix LM
    Osteoporos Int; 2018 Jan; 29(1):61-67. PubMed ID: 28917003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.
    Watts NB; Dore RK; Baim S; Mitlak B; Hattersley G; Wang Y; Rozental TD; LeBoff MS
    Osteoporos Int; 2021 Jan; 32(1):55-61. PubMed ID: 32935170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.